These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. [Responsibility: Towards a fifth principle in blood transfusion's ethics. Applicability and limits of Hans Jonas's responsibility principle]. Nélaton C Transfus Clin Biol; 2016 Sep; 23(3):132-7. PubMed ID: 27424285 [TBL] [Abstract][Full Text] [Related]
8. International challenges of self-sufficiency in blood products. Dhingra N Transfus Clin Biol; 2013 May; 20(2):148-52. PubMed ID: 23643329 [TBL] [Abstract][Full Text] [Related]
9. Some reflections on the Code of Ethics of the International Society of Blood Transfusion. Farrugia A; Del Bò C Blood Transfus; 2015 Oct; 13(4):551-8. PubMed ID: 26057482 [No Abstract] [Full Text] [Related]
10. The revision of the European blood directives: A major challenge for transfusion medicine. Folléa G; Aranko K; Transfus Clin Biol; 2015 Aug; 22(3):141-7. PubMed ID: 26056039 [TBL] [Abstract][Full Text] [Related]
11. Is self-sufficiency financially viable and ethically justifiable?--the role of the National Blood Authority. Adey J Blood Coagul Fibrinolysis; 1994 Dec; 5 Suppl 4():S35-6. PubMed ID: 7795136 [TBL] [Abstract][Full Text] [Related]
12. Economical impact of plasma fractionation project in Iran on affordability of plasma-derived medicines. Cheraghali AM; Aboofazeli R Transfus Med; 2009 Dec; 19(6):363-8. PubMed ID: 19778319 [TBL] [Abstract][Full Text] [Related]
13. [The limits of a principlist approach in the ethics of donation of elements and products of the human body. About some examples]. Thibert JB Transfus Clin Biol; 2020 Aug; 27(3):191-199. PubMed ID: 32621906 [TBL] [Abstract][Full Text] [Related]
14. Production of plasma-derived medicinal products: ethical implications for blood donation and donors. Petrini C Blood Transfus; 2014 Jan; 12 Suppl 1(Suppl 1):s389-94. PubMed ID: 23522886 [No Abstract] [Full Text] [Related]
15. The dynamics of contract plasma fractionation. Farrugia A; Scaramuccia D Biologicals; 2017 Mar; 46():159-167. PubMed ID: 28236560 [TBL] [Abstract][Full Text] [Related]
16. [Voluntary and non-remunerated blood donation; current situation and perspectives]. Monsellier M Transfus Clin Biol; 2017 Sep; 24(3):196-199. PubMed ID: 28705549 [TBL] [Abstract][Full Text] [Related]
17. [Roundtables of SFTS Congress 2013: Needs, indications and safety of blood products; self-sufficiency in blood products]. Hermine O; Lassale B; Morel P; Samama CM; Folléa G; Monsellier M; Noël S; Tissot JD; Lefrère JJ Transfus Clin Biol; 2014 Jun; 21(3):120-31. PubMed ID: 24906893 [TBL] [Abstract][Full Text] [Related]
18. [Introducing marketing strategies and techniques into the field of voluntary blood donation, to meet the rise in blood demand]. Pesavento S; Bégué L Transfus Clin Biol; 2011 Apr; 18(2):198-205. PubMed ID: 21474359 [TBL] [Abstract][Full Text] [Related]
19. Moving on from voluntary non-remunerated donors: who is the best blood donor? Allain JP Br J Haematol; 2011 Sep; 154(6):763-9. PubMed ID: 21539535 [TBL] [Abstract][Full Text] [Related]
20. Management of plasmapheresis in France. Cazenave JP; Folléa G Hematol Cell Ther; 1996 May; 38 Suppl 1():S25-33. PubMed ID: 8933144 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]